Diseases of the Abdomen and Pelvis 2023-2026 : : Diagnostic Imaging.

• Superior document: IDKD Springer Series
• Author: Hodler, Juerg.
• TeilnehmendeR: Kubik-Huch, Rahel A.; Roos, Justus E.; von Schulthess, , Gustav K.
• Place / Publishing House: Cham : : Springer International Publishing AG,, 2023.; ©2023.
• Year of Publication: 2023
• Edition: 1st ed.
• Language: English
• Series: IDKD Springer Series
• Physical Description: 1 online resource (287 pages)

Table of Contents

Intro -- Contents -- 1: Emergency Radiology of the Abdomen and Pelvis -- 1.1 Trauma Part -- 1.1.1 Role of Imaging to Assess Blunt Abdominal Polytrauma (BAT) Patients -- 1.1.1.1 Primary Survey -- 1.1.1.2 Secondary Survey -- Imaging of Common Abdominal Traumatic Injuries -- Intraperitoneal Fluid -- Organ Injuries -- Spleen Injuries -- Liver Injuries -- Urinary Tract Injuries -- Bowel and Mesenteric Injuries -- Diaphragmatic Injuries -- Pancreatic Injuries -- 1.2 Non-Traumatic Abdominal Pain -- 1.2.1 Modalities -- 1.2.2 Right Upper Quadrant -- 1.2.2.1 Acute Cholecystitis -- 1.2.2.2 Duodenal Ulcers -- 1.2.3 Left Upper Quadrant -- 1.2.3.1 Acute Pancreatitis -- 1.2.3.2 Gastritis -- 1.2.4 Right Lower Quadrant Pain -- 1.2.4.1 Acute Appendicitis -- 1.2.4.2 Cecal Inflammation -- 1.2.4.3 Terminal Ileitis -- 1.2.5 Left Lower Quadrant Pain -- 1.2.5.1 Sigmoid Diverticulitis -- 1.2.5.2 Epiploic Appendagitis -- 1.2.5.3 Pelvic Pain: Endometriosis -- 1.2.5.4 Ovarian Torsion -- 1.2.6 Diffuse Abdominal Pain -- 1.2.6.1 Small Bowel Obstruction -- 1.2.6.2 Colonic Obstruction -- 1.2.6.3 Acute Mesenteric Ischemia -- 1.2.7 Concluding Remarks -- References -- 2: Imaging Infectious Disease of the Abdomen (Including COVID-19) -- 2.1 Introduction -- 2.2 Risk Factors for Infections -- 2.2.1 Barrier Disruption -- 2.2.2 Anatomic Obstruction -- 2.2.3 Vascular Compromise -- 2.2.4 Pre-existing Malignancy -- 2.2.5 Immunosuppression -- 2.2.6 Prior Radiation -- 2.2.7 Medical Devices -- 2.2.8 Surgery -- 2.3 Imaging in Abdominal Infections -- 2.3.1 Gastrointestinal Tract Infections -- 2.3.1.1 Clostridioides Difficile Colitis -- 2.3.1.2 Neutropenic Enterocolitis -- 2.3.1.3 Gastrointestinal Tuberculosis -- 2.3.1.4 Viral Enterocolitis -- 2.3.1.5 Fungal Infections -- 2.3.2 Hepatobiliary Infections -- 2.3.2.1 Liver Abscesses.

2.3.2.2 Cholangitis -- 2.3.2.3 Viral Infections -- 2.3.2.4 Parasitic Infections -- 2.3.3 Genitourinary Tract Infections -- 2.3.3.1 Obstructive Uropathy -- 2.3.3.2 Renal and Urinary Bladder Infections -- 2.3.3.3 Prostatic Infections -- 2.3.4 Peritoneal and Abdominal Wall Infections -- 2.3.4.1 Peritoneal Devices -- 2.3.4.2 Intra-abdominal Abscesses -- 2.3.4.3 Abdominal Wall Infections -- 2.4 Conclusion -- References -- 3: Advances in Molecular Imaging and Therapy and Its Impact in Oncologic Imaging -- 3.1 Introduction -- 3.2 Introduction to Theranostics -- 3.2.1 Therapeutic Radionuclides -- 3.2.2 Unique Role of Dosimetry -- 3.2.3 Current Theranostic Agents and Agents in Development -- 3.2.4 Patient Selection for Internal Radiotherapy -- 3.3 Monitoring Disease -- 3.3.1 Response Based on Morphology -- 3.3.2 Response Based on Morphology for Immunotherapy -- 3.3.3 Response Based on FDG PET -- 3.4 Monitoring Liver Disease After SIRT -- 3.4.1 Monitoring SIRT with CT/MRI -- 3.4.2 Monitoring SIRT with PET -- 3.5 Monitoring Neuroendocrine Tumors -- 3.6 Monitoring Metastasized Prostate Cancer -- 3.6.1 Conventional Monitoring of Metastasized Prostate Cancer with CT and Bone Scans -- 3.6.2 Monitoring Metastasized Prostate Cancer with PET/CT -- 3.7 The Role of MRI and PET/MRI for Response Evaluation -- 3.8 Concluding Remarks -- References -- 4: Benign and Malignant Diseases of the Colon and Rectum -- 4.1 Benign Diseases of the Colon and Rectum -- 4.1.1 Inflammatory Diseases of the Colon and Rectum -- 4.1.1.1 Chronic Inflammatory Bowel Diseases -- 4.1.1.2 Infectious Colitis -- Pseudomembranous Colitis -- 4.1.1.3 Non-infectious Colitis -- Ischemic Colitis -- Drug-Induced Colitis -- Neutropenic Colitis -- Radiation Colitis and Proctitis -- Graft-Versus-Host Disease -- 4.1.2 Diverticular Disease and Diverticulitis.

4.1.3 Benign Mucosal Colonic Polyp -- 4.2 Malignant Diseases of the Colon and Rectum -- 4.2.1 Rectal Cancer -- 4.2.1.1 Elective Rectal Cancer Staging -- 4.2.2 Colon Cancer -- 4.2.2.1 Elective Colon Cancer Staging -- 4.2.2.2 Colon Cancer Presenting as Acute Abdomen -- 4.2.3 Evaluation of Response to Neoadjuvant Therapy in Rectal Cancer -- 4.2.3.1 Technique -- 4.2.3.2 Re-staging to Plan Surgery -- 4.2.3.3 The Prognostic Value of Re-staging MR Imaging -- 4.2.3.4 Re-staging to Select Patients for Non-operative Management -- 4.3 Concluding Remarks -- References -- 5: Indeterminate Retroperitoneal Masses -- 5.1 Introduction -- 5.2 Retroperitoneal Space -- 5.3 Tissue Diagnosis -- 5.4 Adipocytic Tumors -- 5.5 Other Soft-Tissue Sarcomas -- 5.6 Neurogenic Tumors -- 5.7 Miscellaneous -- 5.8 Concluding Remarks -- References -- 6: Diffuse Liver Disease -- 6.1 Metabolic and Storage Diseases -- 6.1.1 Steatosis -- 6.1.2 Iron Overload -- 6.1.3 Wilson's Disease -- 6.1.4 Amyloidosis -- 6.1.5 Gaucher Disease -- 6.2 Cirrhosis -- 6.2.1 Imaging of Pre-stages of Cirrhosis -- 6.2.2 Imaging of Cirrhosis -- 6.3 Focal Lesions in Cirrhotic Liver -- 6.3.1 Regenerative Nodules -- 6.3.2 Dysplastic Nodules -- 6.3.3 Malignant Lesions -- 6.3.4 Confluent Focal Fibrosis -- 6.3.5 Standardized Reporting with LI-RADS -- 6.4 Diffuse Vascular Liver Disease -- 6.4.1 Arteriovenous Shunts -- 6.4.2 Budd-Chiari Syndrome -- 6.4.3 Sinusoidal Obstruction Syndrome -- 6.4.4 Passive Hepatic Congestion and Fontan-Associated Liver Disease -- 6.4.5 Hereditary Hemorrhagic Telangiectasia (HHT) -- 6.5 Diffuse Metastatic Disease -- 6.6 Concluding Remarks -- References -- 7: Focal Liver Lesions -- 7.1 Introduction -- 7.2 MDCT Imaging Techniques -- 7.3 MR Imaging Technique -- 7.4 Benign Hepatic Lesions -- 7.4.1 Cysts -- 7.4.2 Hemangioma.

7.4.3 Focal Nodular Hyperplasia (FNH) -- 7.4.4 Hepatocellular Adenoma -- 7.4.5 Biliary Hamartomas (von Meyenburg Complex) -- 7.4.6 Hepatic Abscess and Echinococcus -- 7.5 Malignant Primary Tumors -- 7.5.1 Hepatocellular Carcinoma -- 7.5.2 Fibrolamellar HCC -- 7.5.3 Cholangiocellular Carcinoma -- 7.6 Rare Primary Liver Tumors -- 7.6.1 Biliary Cystadenoma/Cystadenocarcinomas -- 7.6.2 Hepatic Angiosarcoma -- 7.6.3 Epithelioid Hemangioendothelioma -- 7.7 Hepatic Metastases -- 7.8 Differential Diagnosis of Focal Liver Lesions -- 7.9 Concluding Remarks -- References -- 8: Diseases of the Gallbladder and the Biliary Tree -- 8.1 Biliary Tract -- 8.1.1 Normal Anatomy and Variants -- 8.1.2 Congenital Biliary Anomalies -- 8.1.2.1 Choledochal Cysts and Anomalous Pancreatobiliary Ductal Junction -- 8.1.3 Pathologic Conditions -- 8.1.3.1 Choledocholithiasis -- 8.1.3.2 Cholangitis -- Suppurative Cholangitis -- Pyogenic Cholangitis -- Primary Sclerosing Cholangitis -- 8.1.3.3 IgG4 Cholangitis -- 8.1.3.4 Neoplasms of the Biliary System -- Benign Tumors of the Bile Ducts -- Hamartomas and adenomas -- Biliary Intraepithelial Neoplasm and Intraductal Papillary Neoplasms of the Bile Ducts -- Mucinous Cystic Neoplasms -- Malignant Tumors of the Bile Ducts -- Cholangiocarcinoma -- Metastatic Disease -- 8.2 Gallbladder -- 8.2.1 Normal Anatomy -- 8.2.2 Congenital Variants and Anomalies -- 8.2.2.1 Agenesis of the Gallbladder -- 8.2.2.2 Duplication of the Gallbladder -- 8.2.2.3 Phrygian Cap of the Gallbladder -- 8.2.2.4 Diverticula of the Gallbladder, Multiseptate Gallbladder, and Ectopic Gallbladder -- 8.2.3 Pathologic Conditions -- 8.2.3.1 Gallstones -- 8.2.3.2 Acute Cholecystitis -- 8.2.3.3 Acalculous Cholecystitis -- 8.2.3.4 Chronic Cholecystitis -- 8.2.3.5 Hyperplastic Cholecystosis -- 8.2.3.6 Gallbladder Neoplasms -- 8.3 Conclusion.

References -- 9: Diseases of the Pancreas -- 9.1 Developmental Anomalies of the Pancreas -- 9.2 Pancreatic Neoplasms -- 9.2.1 Pancreatic Carcinoma -- 9.2.2 Other Tumors of Ductal Origin -- 9.3 Cystic Neoplasm -- 9.3.1 Serous Cystadenoma -- 9.3.2 Mucinous Cystic Neoplasm (MCN) -- 9.3.3 Intraductal Papillary Mucinous Neoplasm (IPMN) -- 9.4 Other Neoplasm -- 9.4.1 Neuroendocrine Tumors -- 9.4.1.1 Insulinoma -- 9.4.1.2 Gastrinoma -- 9.4.2 Other Rare Pancreatic Neoplasm -- 9.5 Inflammatory Diseases of the Pancreas -- 9.5.1 Acute and Chronic Pancreatitis -- 9.5.2 Autoimmune Pancreatitis -- References -- 10: Adrenal Diseases -- 10.1 Introduction -- 10.2 Incidental Adrenal Mass: No Underlying Malignancy -- 10.2.1 Unenhanced CT -- 10.2.2 CT Contrast-Washout -- 10.2.3 Dual Energy CT -- 10.2.4 MRI -- 10.2.5 FDG PET/CT -- 10.2.6 Lesion Morphology -- 10.2.7 Adrenal Biopsy -- 10.2.8 Management -- 10.3 Evaluation of Adrenal Mass in Patient with Known Extra-Adrenal Malignancy -- 10.4 Evaluation of Patient with Suspected Adrenal Hyperfunction -- 10.4.1 Adrenal Cortical Hyperfunction -- 10.4.2 Adrenal Medullary Hyperfunction -- 10.5 Future Directions -- 10.6 Concluding Remarks -- References -- 11: Benign and Malignant Renal Disease -- 11.1 Introduction -- 11.2 Modalities for Imaging Renal Masses -- 11.2.1 Ultrasound (US) and Contrast-Enhanced US (CEUS) -- 11.2.2 Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) -- 11.3 Very Small Renal Masses (&lt -- 1-1.5 cm) -- 11.4 Cystic Renal Masses -- 11.5 Angiomyolipoma (AML) -- 11.6 Other Solid Renal Masses and Cancer Mimics -- 11.6.1 Oncocytomas -- 11.6.2 Renal Cell Cancers (RCCs) -- 11.6.2.1 Clear Cell Renal Cell Cancer (ccRCC) -- 11.6.2.2 Papillary Renal Cell Cancer (pRCC) -- 11.6.2.3 Chromophobe Renal Cell Cancer (chRCC) -- 11.6.2.4 Uncommon Renal Cancer Cell Types.

11.6.3 Urothelial Neoplasms and Lymphoma.